Sotac Pharmaceuticals Limited Stock

Equities

SOTAC

INE0O2D01012

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:53 2024-05-30 am EDT 5-day change 1st Jan Change
115 INR -2.13% Intraday chart for Sotac Pharmaceuticals Limited -6.16% -2.54%
Sales 2022 732M 8.77M Sales 2023 775M 9.29M Capitalization 1.27B 15.23M
Net income 2022 28M 336K Net income 2023 22M 264K EV / Sales 2022 * -
Net cash position 2022 * - 0 Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 53
Yield 2022 *
-
Yield 2023 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.13%
1 week-6.16%
1 month-6.50%
3 months-25.81%
6 months-8.00%
Current year-2.54%
More quotes
1 week
115.00
Extreme 115
126.00
1 month
113.00
Extreme 113
132.00
Current year
113.00
Extreme 113
155.00
1 year
97.00
Extreme 97
155.00
3 years
97.00
Extreme 97
155.00
5 years
97.00
Extreme 97
155.00
10 years
97.00
Extreme 97
155.00
More quotes
Sotac Pharmaceuticals Limited is an India-based company. The Company is a is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-lactam Syrup and external preparations. The Company is engaged in the business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company’s therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, Cephalosporin. Its pharmaceutical manufacturing facilities are situated at Sanand GIDC-II in Ahmedabad district of Gujarat.
More about the company